Clopidogrel and Aspirin Capsules | CLOPIGOLD A 150

Description

CLOPIGOLD A 150 is a dual antiplatelet therapy designed with the combination of Clopidogrel 75 mg and Aspirin 150 mg, two well-established medicines known for their powerful ability to prevent the formation of blood clots. This combination is widely prescribed for individuals at high risk of heart attack, stroke, and vascular complications. CLOPIGOLD A 150 works by inhibiting platelet aggregation, improving blood flow, and reducing the risk of clot-related cardiovascular events. Manufactured with precision and high-quality standards, this formulation supports long-term heart health and is recommended for patients with coronary artery disease, post-angioplasty care, and other cardiovascular conditions. Uses CLOPIGOLD A 150 is prescribed for several cardiovascular and cerebrovascular conditions, including: Prevention of Heart Attack (Myocardial Infarction) Prevention of Stroke and Transient Ischemic Attacks (TIA) Management of Acute Coronary Syndrome (ACS) Post-Angioplasty and Post-Stent Placement Care Prevention of Blood Clot Formation in High-Risk Patients Peripheral Arterial Disease (PAD) Long-term antiplatelet therapy in individuals with chronic heart diseases Clopidogrel and Aspirin work synergistically to reduce platelet activation and clot formation, making this combination essential for cardiovascular protection. Benefits CLOPIGOLD A 150 offers several clinical advantages: Dual Action: Provides enhanced protection by targeting different pathways of platelet aggregation. Reduces Risk of Clot-Related Events: Significantly lowers the chances of heart attack, recurrent stroke, or blood clot formation. Improves Long-Term Heart Health: Supports stable blood flow, especially in patients with coronary artery disease or stents. Proven Clinical Effectiveness: Both Clopidogrel and Aspirin are well-researched antiplatelet agents with strong clinical evidence. Suitable for Chronic Use: Recommended for long-term therapy in patients with recurrent or ongoing heart and vascular concerns. Enhanced Cardiovascular Safety: Helps prevent life-threatening complications, especially in individuals with a history of cardiovascular events. Dosage The usual recommended dosage for CLOPIGOLD A 150 is one capsule once daily, or as advised by a healthcare professional. It should be taken regularly, at the same time each day, to maintain consistent antiplatelet action. Capsules should be swallowed whole with water; do not chew or crush them. Dosage may differ depending on the patient's medical history, age, or clinical condition. Never stop the medication abruptly without consulting your doctor, as it may increase the risk of clot formation. Side Effects While CLOPIGOLD A 150 is generally well tolerated, some patients may experience: Gastric discomfort or acidity Nausea or vomiting Easy bruising Minor bleeding (such as gum bleeding or nosebleeds) Headache or dizziness Indigestion Rash or mild allergic reactions (rare) Seek medical attention if you notice unusual bleeding, black stools, blood in urine, severe stomach pain, or allergic symptoms. Precautions and Warning Before using CLOPIGOLD A 150, patients should consider the following precautions: Inform the doctor about any existing bleeding disorders, liver disease, or history of ulcers. Use cautiously in patients with asthma or NSAID sensitivity, as Aspirin may aggravate symptoms. Avoid alcohol consumption as it may increase the risk of gastric irritation or bleeding. Patients scheduled for surgery or dental procedures must inform their doctor about this medication. Pregnant or breastfeeding women should consult a healthcare provider before use. Avoid combining with other blood thinners, antacids, or painkillers unless advised by a doctor. Individuals who experience frequent bleeding episodes should report them to their physician immediately. Conclusion CLOPIGOLD A 150, containing Clopidogrel 75 mg + Aspirin 150 mg, is an essential antiplatelet therapy for patients at risk of heart attacks, strokes, and other vascular complications. Its dual-action mechanism offers strong protection against blood clot formation, making it a trusted choice for long-term cardiovascular care. When taken under medical supervision, CLOPIGOLD A 150 supports better heart health, improved blood flow, and reduced risk of life-threatening events. It is a reliable formulation for those requiring continuous antiplatelet support to maintain cardiac stability and overall well-being.